semaglutide lawsuit texas Novo Nordisk protects US patients with legal wins against compounders, including ruling that permanently prohibits compounding pharmacy from selling illegitimate, knockoff Wegovy® or Ozempic® Ozempic Lawsuit Wave Hits Texas
Description
Most clinical guidelines and obesity specialists recommend GLP-1 medications as long-term or indefinite treatments for obesity similar to how blood pressure or cholesterol medications are used chronically
Patients should attend scheduled appointments to assess HbA1c, renal function, and treatment tolerability
Authorization forms
Pennsylvania started paying for GLP-1 drugs for obesity in 2023
Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia
Acknowledgements The authors thank Michael Bonar, Creative Director at the Leicester Diabetes Centre, for the original figure concept
